<code id='B874C3D52E'></code><style id='B874C3D52E'></style>
    • <acronym id='B874C3D52E'></acronym>
      <center id='B874C3D52E'><center id='B874C3D52E'><tfoot id='B874C3D52E'></tfoot></center><abbr id='B874C3D52E'><dir id='B874C3D52E'><tfoot id='B874C3D52E'></tfoot><noframes id='B874C3D52E'>

    • <optgroup id='B874C3D52E'><strike id='B874C3D52E'><sup id='B874C3D52E'></sup></strike><code id='B874C3D52E'></code></optgroup>
        1. <b id='B874C3D52E'><label id='B874C3D52E'><select id='B874C3D52E'><dt id='B874C3D52E'><span id='B874C3D52E'></span></dt></select></label></b><u id='B874C3D52E'></u>
          <i id='B874C3D52E'><strike id='B874C3D52E'><tt id='B874C3D52E'><pre id='B874C3D52E'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:6115
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          After sickle
          After sickle

          MollyFerguson/STATTheapprovalFridayofBluebirdBio’sgenetherapyforsicklecelldiseaseshouldhavebeenamome

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Pfizer plans to depart BIO

          Pfizerplanstoexitamajorbiotechnologyindustrytradeassociation.CindyOrd/GettyImagesforPfizer/BioNTechW